Guggenheim Capital’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-34,907
| Closed | -$747K | – | 1715 |
|
|
2025
Q4 | $747K | Buy |
+34,907
| New | +$715K | 0.01% | 1081 |
|
|
2024
Q4 | – | Sell |
-15,801
| Closed | -$183K | – | 1832 |
|
|
2024
Q3 | $183K | Buy |
15,801
+1,003
| +7% | +$9.46K | ﹤0.01% | 1789 |
|
|
2024
Q2 | $112K | Buy |
14,798
+1,429
| +11% | +$11.8K | ﹤0.01% | 1819 |
|
|
2024
Q1 | $134K | Sell |
13,369
-3,096
| -19% | -$28.8K | ﹤0.01% | 1832 |
|
|
2023
Q4 | $153K | Buy |
+16,465
| New | +$170K | ﹤0.01% | 1825 |
|
|
2019
Q2 | – | Sell |
-26,923
| Closed | -$731K | – | 2149 |
|
|
2019
Q1 | $731K | Sell |
26,923
-25,345
| -48% | -$850K | 0.01% | 1529 |
|
|
2018
Q4 | $1.73M | Buy |
52,268
+8,078
| +18% | +$325K | 0.01% | 1117 |
|
|
2018
Q3 | $2.06M | Buy |
44,190
+32,797
| +288% | +$1.51M | 0.01% | 1222 |
|
|
2018
Q2 | $494K | Sell |
11,393
-17,777
| -61% | -$852K | ﹤0.01% | 1961 |
|
|
2018
Q1 | $1.62M | Sell |
29,170
-3,380
| -10% | -$185K | ﹤0.01% | 1790 |
|
|
2017
Q4 | $1.74M | Sell |
32,550
-38,795
| -54% | -$1.83M | ﹤0.01% | 1769 |
|
|
2017
Q3 | $3.08M | Buy |
71,345
+11,429
| +19% | +$543K | 0.01% | 1362 |
|
|
2017
Q2 | $3.62M | Buy |
59,916
+17,382
| +41% | +$1.03M | 0.01% | 1209 |
|
|
2017
Q1 | $2.95M | Buy |
42,534
+9,194
| +28% | +$639K | 0.01% | 1363 |
|
|
2016
Q4 | $2.22M | Sell |
33,340
-191,635
| -85% | -$12.5M | 0.01% | 1590 |
|
|
2016
Q3 | $14.9M | Sell |
224,975
-74,997
| -25% | -$5.13M | 0.05% | 555 |
|
|
2016
Q2 | $21.7M | Sell |
299,972
-94,176
| -24% | -$6.47M | 0.07% | 502 |
|
|
2016
Q1 | $25.5M | Sell |
394,148
-40,762
| -9% | -$2.7M | 0.08% | 448 |
|
|
2015
Q4 | $31.2M | Sell |
434,910
-113,102
| -21% | -$8.37M | 0.09% | 406 |
|
|
2015
Q3 | $42.1M | Sell |
548,012
-202,730
| -27% | -$16.4M | 0.13% | 223 |
|
|
2015
Q2 | $55.6M | Sell |
750,742
-108,334
| -13% | -$7.8M | 0.14% | 174 |
|
|
2015
Q1 | $62.3M | Sell |
859,076
-62,988
| -7% | -$4.38M | 0.15% | 152 |
|
|
2014
Q4 | $61M | Buy |
922,064
+210,716
| +30% | +$12.9M | 0.15% | 145 |
|
|
2014
Q3 | $39M | Sell |
711,348
-3,251
| -0.5% | -$184K | 0.09% | 330 |
|
|
2014
Q2 | $41.6M | Buy |
714,599
+1,612
| +0.2% | +$94.8K | 0.11% | 282 |
|
|
2014
Q1 | $44.2M | Sell |
712,987
-25,065
| -3% | -$1.46M | 0.13% | 200 |
|
|
2013
Q4 | $39.4M | Buy |
738,052
+6,772
| +0.9% | +$363K | 0.12% | 202 |
|
|
2013
Q3 | $36.7M | Buy |
731,280
+27,448
| +4% | +$1.34M | 0.13% | 152 |
|
|
2013
Q2 | $32.2M | Buy |
+703,832
| New | +$31.5M | 0.14% | 139 |
|
Other funds holding MD
VPM
VCM
WA
Guggenheim Capital's MD Position: Q1 2026 in Review
Guggenheim Capital sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 34,907 shares — an estimated $747K sold.
Guggenheim Capital first reported a position in MD in Q2 2013 and held it in 29 quarters. The position peaked at $62.3M in Q1 2015. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Guggenheim Capital reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
- Guggenheim Capital sold 34,907 Pediatrix Medical shares in Q1 2026, an estimated $747K.
- Guggenheim Capital first reported a position in Pediatrix Medical in Q2 2013 and held it in 29 quarters.
- Guggenheim Capital's Pediatrix Medical position peaked at $62.3M in Q1 2015.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.